Waters... noitazilaicremmoC dna tnempole

Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists
Projects
上一篇:Sei... yalP hctaM eliboM-T ta dael yl
下一篇:Wild... noitcudorP sretnE 6x6 XRT 0001